ResMed Market Sentiment

ResMed Inc

RMDNYSE

Trade with Public

$248.56

2.370.96%

마지막 업데이트: Oct 22, 11:09 AM

$242.34

-3.86-1.57%

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 배당금 비교 옵션 주식 보고서

실적: Q1 2027 실적이 목 10월 29th에 시장 마감 후 7일 후 후에 발표됩니다.

컨퍼런스 콜: 7일 후 4:30 오후에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

ResMed Market Sentiment

Market sentiment signals for ResMed (RMD): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▲ 10.2% short float

Options Flow▲ 0.48 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Neutral

21 analysts

Options Flow (P/C)

0.48

More calls — Bullish

29 calls · 14 puts

Avg Consensus PT

$246

-1.2%

Highest Price Target

$325

+30.8%

UBS

Lowest Price Target

$180

-27.6%

Wolfe Research

Short Interest

10.2%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 15, 2026	RBC Capital	Craig Wong-Pan—	+5.4%	$244 → $262	Upgrade	Sector Perform→Outperform
Aug 31, 2026	Keybanc	Brett Fishbin—	+7.4%	$255 → $267	Maintained	Overweight
Aug 19, 2026	Rothschild & Co	Jackson Philips—	-7.5%	$230	Initiate	Neutral
Aug 7, 2026	RBC Capital	Craig Wong-Pan—	-1.8%	$234 → $244	Maintained	Sector Perform
Aug 7, 2026	Piper Sandler	Adam Maeder—	-9.5%	$233 → $225	Maintained	Neutral
Aug 7, 2026	Keybanc	Brett Fishbin—	+2.6%	$260 → $255	Maintained	Overweight
Aug 7, 2026	Wells Fargo	Nathan Treybeck—	-13.5%	$225 → $215	Maintained	Equal-Weight
Jul 15, 2026	Mizuho	Anthony Petrone—	-11.5%	$235 → $220	Maintained	Outperform
Jul 13, 2026	Citigroup	Laura Sutcliffe—	-5.5%	$270 → $235	Downgrade	Buy→Neutral
Jul 10, 2026	Jefferies	Matthew Taylor—	-9.5%	$240 → $225	Maintained	Hold
Jul 8, 2026	RBC Capital	Craig Wong-Pan—	+11.0%	$321 → $276	Maintained	Outperform
Jul 8, 2026	Wells Fargo	Nathan Treybeck—	-9.5%	$227 → $225	Maintained	Equal-Weight
Jun 22, 2026	Keybanc	Justin Patterson—	+7.0%	$290 → $266	Maintained	Overweight
Jun 17, 2026	Morgan Stanley	David Bailey—	-7.5%	$286 → $230	Downgrade	Overweight→Equal-Weight
Jun 15, 2026	Citigroup	Laura Sutcliffe—	+8.6%	$340 → $270	Maintained	Buy
May 1, 2026	RBC Capital	Craig Wong-Pan—	+29.1%	$314 → $321	Maintained	Outperform
May 1, 2026	Wells Fargo	Nathan Treybeck—	-8.7%	$270 → $227	Maintained	Equal-Weight
Apr 27, 2026	Keybanc	Brett Fishbin—	+16.7%	$302 → $290	Maintained	Overweight
Apr 15, 2026	JP Morgan	David Low—	—	—	Reinstates	Overweight
Apr 9, 2026	Citigroup	Laura Sutcliffe—	+36.8%	$345 → $340	Maintained	Buy
Feb 2, 2026	Citigroup	Laura Sutcliffe—	+38.8%	$330 → $345	Maintained	Buy
Jan 30, 2026	RBC Capital	Craig Wong-Pan—	+26.3%	$311 → $314	Maintained	Outperform
Jan 30, 2026	Piper Sandler	Adam Maeder—	+10.6%	$270 → $275	Maintained	Neutral
Jan 30, 2026	Wells Fargo	Nathan Treybeck—	+8.6%	$265 → $270	Maintained	Equal-Weight
Jan 30, 2026	Stifel	Jonathan Block—	+6.6%	$260 → $265	Maintained	Hold